CAM
ATYR

Close Asset Management’s aTyr Pharma ATYR Stock Holding History

Close Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Sell
12,300
-3,900
-24% -$2.55K ﹤0.01% 239
2026
Q1 		$13K Buy
+16,200
New +$13.7K ﹤0.01% 222

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Close Asset Management's ATYR Position: Q2 2026 in Review

Close Asset Management reduced its aTyr Pharma (ATYR) stake by 24% in Q2 2026, selling an estimated $2.55K and leaving 12,300 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #239.

Close Asset Management first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $13K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Close Asset Management held 12,300 shares of aTyr Pharma worth $7K as of Q2 2026.
  • Close Asset Management sold 3,900 aTyr Pharma shares in Q2 2026, an estimated $2.55K.
  • aTyr Pharma made up ﹤0.01% of Close Asset Management's portfolio in Q2 2026, its #239 holding.
  • Close Asset Management first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • Close Asset Management's aTyr Pharma position peaked at $13K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.